0001401708-24-000092.txt : 20240508
0001401708-24-000092.hdr.sgml : 20240508
20240508204953
ACCESSION NUMBER: 0001401708-24-000092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240508
DATE AS OF CHANGE: 20240508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEECHEM JOSEPH M
CENTRAL INDEX KEY: 0001576195
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35980
FILM NUMBER: 24928176
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 2000
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoString Technologies Inc
CENTRAL INDEX KEY: 0001401708
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 200094687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-378-6266
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
wk-form4_1715215780.xml
FORM 4
X0508
4
2024-05-06
1
0001401708
NanoString Technologies Inc
NSTG
0001576195
BEECHEM JOSEPH M
530 FAIRVIEW AVENUE N
SEATTLE
WA
98109
0
1
0
0
SVP, Research & Development
0
Common Stock
2024-05-06
4
M
0
8460
0
A
149550
D
Common Stock
2024-05-06
4
M
0
104545
0
A
254095
D
Common Stock
2024-05-06
4
M
0
34848
0
A
288943
D
Restricted Stock Units
2024-05-06
4
M
0
8460
0
D
Common Stock
8460
0
D
Restricted Stock Units
2024-05-06
4
M
0
69697
0
D
Common Stock
69697
0
D
Performance Restricted Stock Units
2024-05-06
4
M
0
104545
0
D
Common Stock
104545
0
D
The shares have not been delivered to the reporting person.
Each RSU represents a contingent right to receive one (1) share of Issuer's common stock.
Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a Change of Control under the terms of the RSU award agreement, the vesting of the RSUs accelerated.
Each Performance Restricted Stock Unit ("PSU") represents a contingent right to receive one (1) share of Issuer's common stock.
Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a Change of Control under the terms of the PSU award agreement, the vesting of the PSUs accelerated.
/s/ Shannon Atchison, Attorney in Fact
2024-05-08